Dernières nouvelles pour Saratoga Investment (NYSE:SAR) Stock

Saratoga Investment

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Saratoga Investment Corp

SARASELECT NAMEN -ANTEILE by SARASELECT

Sarcophagus

Sanford Ltd

SABRE RESOURCES LTD by Sabre Resources Ltd.

Sabre Resources Ltd

Tradr 2X Short Innovation Daily ETF

SOUTHERN ARC MINERLS A by Southern Arc Minerals Inc.

Southern Arc Minerals Inc

StandardAero Inc

Sartorius AG

Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) ("Saratoga Investment" or "the Company"), a business development company, today announced that its Board of Directors has declared a base quarterly dividend of $0.74 per share for the fiscal third quarter ending November 30, 2024, and an additional special dividend of $0.35 per share fulfilling our fiscal 2024 distribution requirements. Both dividends are payable on December 19, 2024, to all stockholders of record at the close of business on December 4, 2024.&nbsp;

News

Dividends

Saratoga Investment Corp. Announces Special Dividend Of $0.35 Per Share Fulfilling Fiscal 2024 Distribution Requirements

Compass Point analyst Casey Alexander maintains Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) with a Buy and raises the price target from $24.75 to $26.25.

Price Target

Analyst Ratings

Compass Point Maintains Buy on Saratoga Investment, Raises Price Target to $26.25

B. Riley Securities analyst Bryce Rowe reiterates Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) with a Neutral and maintains $25 price target.

Reiteration

B. Riley Securities Reiterates Neutral on Saratoga Investment, Maintains $25 Price Target

Oppenheimer analyst Mitchel Penn maintains Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) with a Perform and raises the price target from $23 to $25.

Oppenheimer Maintains Perform on Saratoga Investment, Raises Price Target to $25

Ladenburg Thalmann analyst Mickey Schlelen downgrades Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) from Buy to Neutral.

Downgrades

Ladenburg Thalmann Downgrades Saratoga Investment to Neutral

Shares of Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) rose sharply in today's pre-market trading after the company reported better-than-expected earnings and sales results <a href="https://www.benzinga.com/quote/SAR/earnings">for its second quarter</a>.
The company reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of 94 cents per share.
Saratoga Investment shares jumped 7.9% to $25.43 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Carmell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) rose 52.5% to $0.5118 in pre-market trading after dipping 5% on Tuesday.</li>
<li>WW International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) rose 42.4% to $1.65 in pre-market trading. WW shares jumped 47% on Tuesday after the company announced the addition of compounded semaglutide into its offering.</li>
<li>Arcadium Lithium plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NASDAQ">ALTM</a>) gained 31.1% to $5.56 in pre-market trading after Rio Tinto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) announced plans to acquire the company in an all-cash transaction for $5.85 per share.</li>
<li>Kezar Life Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZR#NASDAQ">KZR</a>) shares rose 20.3% to $0.8850 in pre-market trading. Tang Capital Management disclosed a 9.9% active stake in Kezar Life Sciences with 7.2 million shares acquired for $5.6 million.</li>
<li>iCoreConnect Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCT#NASDAQ">ICCT</a>) shares gained 16.1% to $0.4150 in pre-market trading. iCoreConnect recently announced it acquired substantially all of the assets of the Healthcare Circle of Excellence..</li>
<li>PLBY Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBY#NASDAQ">PLBY</a>) shares surged 12% to $0.80 in pre-market trading.</li>
<li>The Oncology Institute, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) shares jumped 10.2% to $0.3449 in pre-market trading after declining around 4% on Tuesday.</li>
<li>IN8bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) gained 9.5% to $0.2466 in pre-market trading after dipping around 12% on Tuesday.</li>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) rose 7.5% to $1.86 in pre-market trading after declining 8% on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Paltalk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALT#NASDAQ">PALT</a>) shares dipped 20.2% to $2.45 in pre-market trading after falling around 4% on Tuesday.</li>
<li>Kidpik Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) shares declined 19.6% to $1.76 in pre-market trading.</li>
<li>Moolec Science SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLEC#NASDAQ">MLEC</a>) fell 19.2% to $0.7100 in today's pre-market trading. The company recently reported a loss for the fourth quarter.</li>
<li>LeddarTech Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDTC#NASDAQ">LDTC</a>) shares fell 18.7% to $0.22 in pre-market trading after gaining 3% on Tuesday.</li>
<li>Nature&#8217;s Miracle Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) fell 17% to $0.1632 in pre-market trading after gaining 45% on Tuesday.</li>
<li>Ambow Education Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#NYSE">AMBO</a>) shares declined 15.8% to $3.52 in pre-market trading after gaining 4% on Tuesday.</li>
<li>Royalty Management Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMCO#NASDAQ">RMCO</a>) shares fell 14.7% to $0.7865 in pre-market trading after declining 3% on Tuesday.</li>
<li>Ontrak, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) shares fell 14.2% to $2.37 after jumping 52% on Tuesday.</li>
<li>Delek Logistics Partners, LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKL#NYSE">DKL</a>) fell 10.2% to $40.11 in pre-market trading. Delek Logistics Partners priced its public offering of 3,846,153 common units at $39 per unit.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) declined 7.3% to $8.92 in pre-market trading after dipping around 16% on Tuesday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41238686/jim-cramer-ast-spacemobile-is-just-too-hot-recommends-buying-this-tech-stock">Jim Cramer: AST SpaceMobile Is &#8216;Just Too Hot,&#8217; Recommends Buying This Tech Stock</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALTM

AMBO

CTCX

ICCT

INAB

LDTC

MLEC

NMHI

OTRK

PALT

PLBY

RMCO

TIGR

Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Helen of Troy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) to report quarterly earnings at $1.04 per share on revenue of $458.24 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Helen of Troy shares gained 2.5% to $63.93 in after-hours trading.</li>
<li>Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported better-than-expected earnings and sales results for its second quarter. The company reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of 94 cents per share. Saratoga Investment shares gained 8.1% to $25.50 in the after-hours trading session.</li>
<li>Analysts expect AZZ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) to post quarterly earnings at $1.32 per share on revenue of $411.8 million. The company will release earnings after the markets close. AZZ shares gained 1% to $81.50 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Cardiol Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDL#NASDAQ">CRDL</a>) announced a preliminary prospectus for a proposed public offering of common stock. However, the size of the offering was not disclosed. Cardiol Therapeutics shares dipped 11.7% to $1.7301 in the after-hours trading session.</li>
<li>Analysts expect E2open Parent Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) to post quarterly earnings at 5 cents per share on revenue of $154.82 million after the closing bell. E2open shares gained 2.5% to $4.11 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41238686/jim-cramer-ast-spacemobile-is-just-too-hot-recommends-buying-this-tech-stock">Jim Cramer: AST SpaceMobile Is &#8216;Just Too Hot,&#8217; Recommends Buying This Tech Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

CRDL

ETWO

HELE

AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $0.94 by 41.49 percent. The company reported quarterly sales of $43.003 million which beat the analyst consensus estimate of $37.124 million by 15.84 percent. This is a 21.09 percent increase over sales of $35.514 million the same period last year.

Earnings Beats

Saratoga Investment Q2 2025 Adj. EPS $1.33 Beats $0.94 Estimate, Sales $43.003M Beat $37.124M Estimate

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects PepsiCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) to report quarterly earnings at $2.29 per share on revenue of $23.83 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. PepsiCo shares fell 0.5% to close at $167.21 on Monday.</li>
<li>MEDIROM Healthcare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) said it acquired all of the rehabilitation centers of Y's, Inc. However, the terms of the transaction were not disclosed. MEDIROM Healthcare shares gained 7.2% to $2.84 in the after-hours trading session.</li>
<li>Analysts are expecting Accolade, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) to post a quarterly loss at 44 cents per share on revenue of $105.01 million. The company will release earnings before the markets open. Accolade shares gained 3% to $4.0899 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Benchmark Electronics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) named Bryan Schumaker as the company&#8217;s chief financial officer effective Oct. 8. Benchmark Electronics shares fell 0.1% to $43.69 in the after-hours trading session.</li>
<li>Analysts expect Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) to post quarterly earnings at 94 cents per share on revenue of $37.12 million after the closing bell. Saratoga Investment shares gained 0.8% to $23.45 in after-hours trading.</li>
</ul>
Check This Out:
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41213879/top-3-financials-stocks-that-may-jump-this-quarter">Top 3 Financials Stocks That May Jump This Quarter</a></li>
</ul>
Photo courtesy: Shutterstock

ACCD

PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) is gearing up to announce its quarterly earnings on Tuesday, 2024-10-08. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Saratoga Investment will report an earnings per share (EPS) of $0.94.
Investors in Saratoga Investment are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
The company's EPS beat by $0.12 in the last quarter, leading to a 2.72% increase in the share price on the following day.
Here's a look at Saratoga Investment's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.93</td>
<td>0.95</td>
<td>1.03</td>
<td>1.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.05</td>
<td>0.94</td>
<td>1.01</td>
<td>1.08</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>-1.0%</td>
<td>-10.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1728316824_0.png" alt="eps graph" />
<h3>Market Performance of Saratoga Investment's Stock</h3>
Shares of Saratoga Investment were trading at $23.24 as of October 04. Over the last 52-week period, shares are down 1.86%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SAR/earnings">To track all earnings releases for Saratoga Investment visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Saratoga Investment

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financials sector.
<h3 class="wp-block-heading">Ready Capital Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>)</h3>
<ul>
<li>Dividend Yield: 15.73%</li>
<li>Wedbush analyst Jay McCanless reiterated a Neutral rating with a price target of $9 on Aug. 12. This analyst has an accuracy rate of 84%.</li>
<li>BTIG analyst Timothy Hayes assumed coverage on the stock with a Neutral rating on July 19. This analyst has an accuracy rate of 76%.</li>
<li>Recent News: On Aug. 7, the company posted net book value of $12.97 per share of common stock as of June 30, 2024.</li>
<li>Benzinga Pro's real-time newsfeed alerted to l<a href="https://pro.benzinga.com/dashboard">atest RC news</a></li>
</ul>
<h3 class="wp-block-heading">Apollo Commercial Real Estate Finance, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARI#NYSE">ARI</a>)</h3>
<ul>
<li>Dividend Yield: 13.54%</li>
<li>JP Morgan analyst Richard Shane maintained a Neutral rating and raised the price target from $9.5 to $10 on July 16. This analyst has an accuracy rate of 68%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintained a Market Perform rating and cut the price target from $11 to $10 on May 1. This analyst has an accuracy rate of 77%.</li>
<li>Recent News: On Aug. 6, the company posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://pro.benzinga.com/dashboard"> trend in ARI stock</a>.</li>
</ul>
<h3 class="wp-block-heading">Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>)</h3>
<ul>
<li>Dividend Yield: 12.40%</li>
<li>B. Riley Securities analyst Bryce Rowe reiterated a Neutral rating with a price target of $25 on July 11. This analyst has an accuracy rate of 60%.</li>
<li>Compass Point analyst Casey Alexander downgraded the stock from Buy to Neutral with a price target of $24.75 on Jan. 10. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On Aug. 22, Saratoga Investment announced a quarterly dividend of 74 cents per share for the fiscal second quarter ending Aug. 31, 2024.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://pro.benzinga.com/dashboard">breakout in SAR shares.</a></li>
</ul>

<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40723564/s-p-500-nasdaq-fall-for-2nd-straight-session-amid-nvidia-decline-fear-greed-index-in-neutral-zone">S&amp;P 500, Nasdaq Fall For 2nd Straight Session Amid Nvidia Decline: Fear &amp; Greed Index In &#8216;Neutral&#8217; Zone</a></li>
</ul>

Wall Street's Most Accurate Analysts Spotlight On 3 Financials Stocks With Over 12% Dividend Yields

Compass Point analyst Casey Alexander upgrades Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) from Neutral to Buy and maintains the price target from $24.75 to $24.75.

Upgrades

Compass Point Upgrades Saratoga Investment to Buy, Maintains Price Target to $24.75

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.93 by 12.9 percent. This is a 2.78 percent decrease over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $38.68 million which beat the analyst consensus estimate of $36.47 million by 6.05 percent. This is a 11.68 percent increase over sales of $34.63 million the same period last year.

Saratoga Investment Q1 Adj $1.05 Beats $0.93 Estimate, Sales $38.68M Beat $36.47M Estimate

As of June 10, 2024, five stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">UP Fintech Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>)</h3>
<ul>
<li>On June 5, UP Fintech Holding reported a year-over-year increase in first-quarter sales results. Mr. Wu Tianhua, Chairman and CEO of UP Fintech stated, &#8220;Market backdrop was more active in the first quarter, total revenue in the first quarter was US$78.9 million, representing a 12.8% increase sequentially and 19.0% increase compared to the same quarter last year. Benefiting from our brand strength and R&amp;D capabilities, both GAAP and non-GAAP net income experienced significant growth.&#8221; GAAP The company's stock gained around 11% over the past five days and has a <a href="https://www.benzinga.com/quote/TIGR">52-week high of $5.80</a>.</li>
<li>RSI Value: 72.85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>TIGR Price Action: Shares of UP Fintech gained 5.9% to close at $4.75 on Friday.</li>
</ul>
<h3 class="wp-block-heading">PennantPark Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNNT#NYSE">PNNT</a>)</h3>
<ul>
<li>On May 8, Pennant Park Investment posted downbeat quarterly results. &#8220;We are pleased to announce an increase in our monthly dividend based on the continued strong underlying credit performance of our portfolio,&#8221; said Arthur Penn, Chairman and CEO.  &#8220;Our earnings stream continues to be robust and is driven in part by the  excellent returns generated by our PSLF Joint Venture.&#8221; The company's stock gained around 6% over the past month and <a href="https://www.benzinga.com/quote/PNNT">has a 52-week high</a> of $7.73.</li>
<li>RSI Value: 72.03</li>
<li>PNNT Price Action: Shares of PennantPark Investment rose 0.8% to close at $7.72 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Saratoga Investment Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>)</h3>
<ul>
<li>On May 23, Saratoga Investment raised its quarterly dividend from 73 cents to 74 cents per share. The company's stock gained around 5% over the past month and has a <a href="https://www.benzinga.com/quote/SAR">52-week high</a> of $28.15.</li>
<li>RSI Value: 71.18</li>
<li>SAR Price Action: Shares of Saratoga Investment gained 0.4% to close at $24.29 on Friday.</li>
</ul>
<h3 class="wp-block-heading">FS KKR Capital Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSK#NYSE">FSK</a>)</h3>
<ul>
<li>On June 6, FSK completed public offering of $600 million 6.875% unsecured notes due 2029. The company's stock jumped around 4% over the past month and has a 52-week high is $20.99.</li>
<li>RSI Value: 71.12</li>
<li>FSK Price Action: Shares of FS KKR Capital gained 0.2% to close at $20.62 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Hagerty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGTY#NYSE">HGTY</a>)</h3>
<ul>
<li>On May 7, Hagerty posted mixed quarterly results. &#8220;We are off to a great start in 2024 as the initiatives undertaken in 2023 powered strong top-line momentum and significant margin expansion,&#8221; said McKeel Hagerty, Chief Executive Officer and Chairman of Hagerty. The company's stock jumped around 14% over the past month and &lt;a href=&#8221;https://www.benzinga.com/quote/HGTY&#8221;&gt;&lt;em&gt; has a 52-week high &lt;/em&gt;&lt;/a&gt; of $10.10.</li>
<li>RSI Value: 75.30</li>
<li>HGTY Price Action: Shares of Hagerty rose 3% to close at $10.10 on Friday.</li>
</ul>
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39226950/jim-cramer-is-worried-about-palo-alto-networks-calls-monday-com-really-good">Jim Cramer Is &#8216;Worried&#8217; About Palo Alto Networks, Calls Monday.com &#8216;Really Good</a>&#8216;

Short Ideas

HGTY

PNNT

Top 5 Financial Stocks That May Collapse This Quarter

Saratoga Investment Raises Quarterly Dividend From $0.73 To $0.74

Oppenheimer analyst Mitchel Penn downgrades Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) from Outperform to Perform and lowers the price target from $24 to $23.

Oppenheimer Downgrades Saratoga Investment to Perform, Lowers Price Target to $23

Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) ("Saratoga Investment" or "the Company"), a business development company, today announced that its Board of Directors has declared a quarterly dividend of $0.73 per share for the fiscal fourth quarter ended February 29, 2024, an increase of $0.01 from $0.72 per share in the prior fiscal third quarter, and the sixteenth quarterly dividend increase in a row. Total dividends for fiscal year 2024 are $2.85 per share, an increase of 16.8% over the prior year. This fourth quarter dividend is payable on March 28, 2024, to all stockholders of record at the close of business on March 13, 2024.
"We continue to benefit from the elevated level of interest rates on our largely floating rate assets combined with the growth of our overall portfolio in well-selected industry segments, resulting in healthy earnings growth this past year," said&nbsp;Christian L. Oberbeck, Chairman and Chief Executive Officer of&nbsp;Saratoga Investment. "Saratoga's fourth quarter dividend of 73c per share reflects an approximately 6% increase year-over-year and a 38% increase over the past two years. Annualizing this dividend rate implies a 12.8% dividend yield based on Saratoga's recent stock price of&nbsp;$22.77&nbsp;per share on&nbsp;February 13, 2024. Our current substantial overearning of the dividend increases Net Asset Value, supports increased portfolio growth and provides a cushion against adverse events, including potential cuts in interest rates in 2024."
This is the fourth dividend declared in fiscal year 2024. Total dividends for fiscal year 2024 are $2.85 per share, an increase of 16.8% over the prior year's total dividends of $2.44 per share. The Company previously declared a quarterly dividend of $0.72 per share for the quarter ended November 30, 2023, $0.71 per share for the quarter ended August 31, 2023 and $0.70 per share for the quarter ended May 31, 2023. During fiscal 2023 the Company declared a quarterly dividend of $0.69 per share for the quarter ended February 28, 2023, $0.68 per share for the quarter ended November 30, 2022, $0.54 per share for the quarter ended August 31, 2022 and $0.53 per share for the quarter ended May 31, 2022.
Shareholders will have the option to receive payment of the dividend in cash or receive shares of common stock pursuant to the Company's dividend reinvestment plan ("DRIP"). Saratoga Investment shareholders who hold their shares with a broker must affirmatively instruct their brokers prior to the record date if they prefer to receive this dividend, and future dividends, in common stock.&nbsp; The number of shares of common stock to be delivered shall be determined by dividing the total dollar amount by 95% of the average of the market prices per share at the close of trading on the ten (10) trading days immediately preceding (and including) the payment date.

Saratoga Investment Corp. Increases Quarterly Dividend From $0.72 To $0.73 Per Share

Shares of WD-40 Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wdfc#NASDAQ">WDFC</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected first-quarter results.
WD-40 reported quarterly earnings of $1.28 per share which exceeded the analyst consensus estimate of $1.05 per share. The company reported quarterly sales of $140.42 million, clocking in above the Street&#39;s estimate of $134.37 million.
WD-40 shares jumped 17.3% to $277.56 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Nauticus Robotics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kitt#NASDAQ">KITT</a>) climbed 87.8% to $0.5501. Nauticus Robotics secured additional funding and appointed John W. Gibson, Jr as interim CEO.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) shares jumped 47.7% to $3.0570. Clearmind Medicine completed a Type A Meeting with the FDA for clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of alcohol use disorder.</li>
<li>Sana Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sana#NASDAQ">SANA</a>) gained 46.8% to $7.57. Sana Biotechnology recently announced FDA clearance of investigational new drug application for SC262.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) jumped 37.8% to $4.98.</li>
<li>Vicarious Surgical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rbot#NASDAQ">RBOT</a>) rose 37% to $0.6851.</li>
<li>Nvni Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvni#NASDAQ">NVNI</a>) climbed 35.2% to $2.6091.</li>
<li>EchoStar Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sats#NASDAQ">SATS</a>) gained 31% to $16.50. EchoStar completed merger with DISH Network Corporation.</li>
<li>Amarin Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrn#NASDAQ">AMRN</a>) climbed 28.8% to $1.25 after the company reported strong preliminary FY23 total revenues.</li>
<li>Exicure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xcur#NASDAQ">XCUR</a>) shares rose 17% to $0.5501. Exicure was granted broad U.S. patent #11866700 for &quot;Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer&#39;s).&quot;</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) gained 16.2% to $13.72.</li>
<li>Exscientia plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exai#NASDAQ">EXAI</a>) rose 14% to $7.07. B of A Securities recently downgraded the stock from Buy to Neutral and lowered its price target from $11 to $9.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) rose 13.6% to $14.00.</li>
<li>SMART Global Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgh#NASDAQ">SGH</a>) gained 13.4% to $20.97 after the companyy posted better-than-expected earnings for its first quarter and announced approval of $75 million share repurchase authorization.</li>
<li>Xeris Biopharma Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xers#NASDAQ">XERS</a>) jumped 12.4% to $2.7100. Xeris Biopharma entered into an exclusive worldwide license agreement with Amgen for Xeriject formulation of teprotumumab for thyroid eye disease.</li>
<li>GoodRx Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdrx#NASDAQ">GDRX</a>) jumped 11.6% to $6.38. GoodRx sees preliminary FY23 adjusted revenue of $759 million to $761 million.</li>
<li>E2open Parent Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etwo#NYSE">ETWO</a>) surged 11.2% to $4.27 following strong quarterly sales.</li>
<li>PriceSmart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psmt#NASDAQ">PSMT</a>) rose 10% to $80.25 as the company reported better-than-expected earnings for its first quarter on Tuesday.</li>
<li>iCoreConnect Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icct#NASDAQ">ICCT</a>) shares rose 9.3% to $1.4203. iCoreConnect announced strategic acquisition of Verifi Dental.</li>
<li>AZZ Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/azz#NYSE">AZZ</a>) jumped 9.1% to $62.24 following upbeat quarterly results.</li>
<li>Intuitive Surgical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isrg#NASDAQ">ISRG</a>) gained 6.1% to $350.63. Intuitive Surgical said it sees preliminary revenue of $1.93 billion for the fourth quarter, versus market estimates of $1.87 billion.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>DocGo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcgo#NASDAQ">DCGO</a>) shares fell 32.9% to $3.2150. Fuzzy Panda Research issued a report and disclosed a short position in the stock.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) shares fell 25.3% to $2.10 after dipping 26% on Tuesday.</li>
<li>Aclaris Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acrs#NASDAQ">ACRS</a>) fell 25% to $0.9601 after the company&#39;s Phase 2B study of ATI-1777 2% QD was not statistically superior on the primary efficacy endpoint.</li>
<li>Presto Automation Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prst#NASDAQ">PRST</a>) fell 19.5% to $0.3127.</li>
<li>Roma Green Finance Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roma#NASDAQ">ROMA</a>) shares fell 18.8% to $2.3557 after dipping over 27% on Tuesday. Roma Green Finance announced pricing of $12.3 million public offering of 2,449,943 of shares at price of $4.00 per share.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) fell 16.8% to $14.11. Sidus Space regained compliance with Nasdaq minimum bid requirements.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) fell 15.7% to $0.3797.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) shares fell 15.1% to $18.97 after the company lowered its full-year revenue guidance.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) fell 14.9% to $2.22.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) fell 14.4% to $1.61.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) declined 12.9% to $0.1335.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) fell 12.4% to $18.38 after the company reported preliminary BRIUMVI US net product sales for Q4 and FY23.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) fell 12% to $4.2350.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) fell 11.9% to $0.2621 after gaining 22% on Tuesday.</li>
<li>Veradigm Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdrx#NASDAQ">MDRX</a>) fell 11.1% to $9.56. Veradigm said it sees FY23 revenue of $608 million to $622 million.</li>
<li>Galera Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grtx#NASDAQ">GRTX</a>) shares fell 9.1% to $0.1919 after jumping 41% on Tuesday.</li>
<li>Saratoga Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sar#NYSE">SAR</a>) fell 9.1% to $23.55 following downbeat quarterly earnings.</li>
<li>NovoCure Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvcr#NASDAQ">NVCR</a>) declined 8.8% to $13.43.</li>
<li>Sasol Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>) shares fell 6.8% to $9.08.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/01/36571171/how-to-earn-500-a-month-from-jpmorgan-stock-ahead-of-q4-earnings-report"> How To Earn $500 A Month From JPMorgan Stock Ahead Of Q4 Earnings Report</a>

Penny Stocks

Small Cap

Intraday Update

ACRS

AEHR

AIMD

AMRN

CMND

DCGO

EXAI

GDRX

GRTX

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

ISRG

KITT

MDRX

NAMS

NEXI

NVCR

NVNI

PRST

PSMT

RBOT

ROMA

SANA

SATS

SIDU

TCRT

TGTX

WDFC

WLDS

XCUR

XERS

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday.
Shares of Veradigm Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdrx#NASDAQ">MDRX</a>) shares fell sharply during Wednesday&rsquo;s session.
Veradigm said it sees FY23 revenue of $608 million to $622 million. The company also sees FY23 Non-GAAP EPS of 79 cents to 88 cents.
Veradigm shares tumbled 11.1% to $9.56 on Wednesday.
Here are some other big stocks recording losses in today&rsquo;s session.
<ul>
<li>DocGo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcgo#NASDAQ">DCGO</a>) shares dipped 32.9% to $3.2150. Fuzzy Panda Research issued a report and disclosed a short position in the stock.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) shares declined 15.1% to $18.97 after the company lowered its full-year revenue guidance.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) shares tumbled 14.4% to $1.61.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) declined 12.4% to $18.38 after the company reported preliminary BRIUMVI US net product sales for Q4 and FY23.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) declined 12% to $4.2350.</li>
<li>Monte Rosa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glue#NASDAQ">GLUE</a>) fell 10.2% to $6.92.</li>
<li>Saratoga Investment Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sar#NYSE">SAR</a>) declined 9.1% to $23.55 following downbeat quarterly earnings.</li>
<li>NovoCure Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvcr#NASDAQ">NVCR</a>) dipped 8.8% to $13.43.</li>
<li>Coherus BioSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chrs#NASDAQ">CHRS</a>) fell 8.3% to $2.73. Coherus Biosciences announced the termination of its tigit program collaboration with Shanghai Junshi Biosciences, with plans to wind down their work in the coming months.</li>
<li>Tilray Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) fell 8.1% to $1.94. Tilray filed prospectus supplement to register the resale of 12.4 million shares of common stock by selling stockholder.</li>
<li>Mirum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mirm#NASDAQ">MIRM</a>) fell 7.7% to $25.75. Mirum Pharmaceuticals recently announced preliminary unaudited 2023 net revenue and issued corporate updates.</li>
<li>Sasol Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssl#NYSE">SSL</a>) shares declined 6.8% to $9.08.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) fell 6.7% to $37.35.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) fell 6.2% to $5.41.</li>
<li>iRobot Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irbt#NASDAQ">IRBT</a>) fell 6.1% to $34.81.</li>
<li>Arcadium Lithium plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/altm#NASDAQ">ALTM</a>) fell 6% to $6.11.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) shares declined 4.7% to $144.85 after the SEC&#39;s X account was compromised on Tuesday. The SEC said it has not approved the listing and trading of spot <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment/">bitcoin</a> exchange-traded products.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/01/36577360/dow-surges-100-points-pricesmart-earnings-top-views"> Dow Surges 100 Points; PriceSmart Earnings Top Views</a>

CHRS

COIN

GLUE

IRBT

MIRM

TLRY

WOLF

Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday

Oppenheimer analyst Mitchel Penn maintained a Hold rating on Saratoga Investment (SAR – Research Report) today. The company's shares closed yesterd...

Oppenheimer Sticks to Its Hold Rating for Saratoga Investment (SAR)

In a report released yesterday, Michael Diana from Maxim Group reiterated a Buy rating on Saratoga Investment (SAR – Research Report). The company'...

Maxim Group Keeps Their Buy Rating on Saratoga Investment (SAR)

A Game Plan For BDC Investors Before The Earnings Season

Saratoga Investment: 12% Yield That Is Not Worth The Risk

BDC Weekly Review: Dividend Capture Is A Tough Gig

3 BDCs With Highest Dividend Coverage Levels: Only One Is A Defensive Leader

Important Message For BDC Investors Based On First Q3 Earnings Reports

Saratoga Investment declares $0.74 dividend

Lucid Capital initiated coverage of Saratoga Investment (SAR) with a Buy rating and $27 price target Before 2024, Saratoga had a long track record ...

Saratoga Investment initiated with a Buy at Lucid Capital

I'm Putting +9% Yields Under My Income Tree

BBDC

BXSL

CSWC

FDUS

GAIN

GAINL

GAINN

GAINZ

GLAD

HTGC

KBDC

MAIN

MSDL

OBDC

OBDE

TSLX

Press Releases

Saratoga Investment Corp. Increases Quarterly Dividend by  $0.01, or 1.4%, to $0.74 per Share for the  Fiscal First Quarter Ended May 31, 2024

Saratoga Investment Corp. to Report Fiscal First Quarter 2025 Financial Results and Hold Conference Call

Saratoga Investment Corp. Announces Fiscal First Quarter 2025 Financial Results

Saratoga Investment Corp. Announces Distribution of Proxy Materials for its 2024 Annual Meeting of Stockholders

Saratoga Investment Corp. Announces Quarterly Dividend of $0.74 per Share for the Fiscal Second Quarter Ending August 31, 2024

Saratoga Investment Corp. to Report Fiscal Second Quarter 2025 Financial Results and Hold Conference Call

Saratoga Investment Corp. Announces Postponement of Annual Meeting of Stockholders Until October 23, 2024

Saratoga Investment Corp. Announces Fiscal Second Quarter 2025 Financial Results

Saratoga Investment Corp. Announces Quarterly Dividend of $0.74 Per Share for the Fiscal Third Quarter Ending November 30, 2024

Saratoga Investment Corp. to Report Fiscal Third Quarter 2025 Financial Results and Hold Conference Call

AlTi Global

ArrowMark Financial Corp. - Closed End Fund

ArrowMark Financial

Bridge Investment Group Holdings Inc. Class A Common Stock

Bridge Investment Group

CION Invt

Diamond Hill Investment Group, Inc. - Class A Common Stock

Diamond Hill Investment

Ellington Credit Company Common Shares of Beneficial Interest

Ellington Credit

Gladstone Investment Corporation - Business Development Company

Gladstone Inv

GCM Grosvenor Inc. - Class A Common Stock

GCM Grosvenor

Great Elm Capital Corp. - Closed End Fund

Great Elm Capital

Horizon Technology Finance Corporation - Common Stock

Horizon Tech Finance

Innventure

Chicago Atlantic BDC, Inc. - Common Stock

Chicago Atlantic BDC

Monroe Capital Corporation - Closed End Fund

Monroe Cap

OFS Credit Company, Inc. - Closed End Fund

OFS Credit Co

Oxford Square Capital Corp. - Closed End Fund

Oxford Square Cap

PennantPark Investment Corporation Common Stock

Pennant Park Investment

Palmer Square Capital BDC Inc. Common Stock

Palmer Square Capital BDC

Portman Ridge Finance Corporation - Closed End Fund

Portman Ridge Finance

Runway Growth Finance Corp. - Common Stock

Runway Gwth Fin

Silvercrest Asset Management Group Inc. - Common Stock

Comments

Saratoga Investment

Actualités

Dernières nouvelles pour Saratoga Investment (NYSE:SAR) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL